2.37
0.14 (6.28%)
0.14 (6.28%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 4,614,924 |
|
|||||
| News | - | ||||||
| Day High | 2.455 | Low High |
|||||
| Day Low | 2.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Adma Biologics Inc | ADMA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.14 | 6.28% | 2.37 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.27 | 2.25 | 2.455 | 2.37 | 2.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,406 | 4,614,924 | $ 2.42 | $ 11,152,633 | - | 1.01 - 2.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:19 | 1 | $ 2.45 | USD |
Period:
Draw Mode:
Adma Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 465.35M | 196.35M | 188.45M | $ 80.94M | $ -63.09M | -0.51 | -4.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.20% |
Adma Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADMA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.08 | 2.48 | 1.97 | 2.15 | 2,804,016 | 0.29 | 13.94% |
| 1 Month | 2.26 | 2.48 | 1.97 | 2.16 | 1,865,397 | 0.11 | 4.87% |
| 3 Months | 2.07 | 2.48 | 1.82 | 2.08 | 2,581,232 | 0.30 | 14.49% |
| 6 Months | 1.655 | 2.48 | 1.38 | 1.93 | 2,574,732 | 0.715 | 43.2% |
| 1 Year | 1.59 | 2.48 | 1.01 | 1.61 | 2,730,810 | 0.78 | 49.06% |
| 3 Years | 3.53 | 6.00 | 1.01 | 2.28 | 3,111,056 | -1.16 | -32.86% |
| 5 Years | 2.85 | 7.04 | 1.01 | 2.44 | 2,045,827 | -0.48 | -16.84% |
Adma Biologics Description
| ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. |